Kellogg was vice president and general manager of Smiths Medical's diabetes division. He was responsible for the commercialization of Smiths Medical's Deltec insulin pumps in the U.S. and foreign markets, including hiring and training a new sales force, establishing customer service and creating the clinical service function.
"We are pleased to have someone with Rod's experience and accomplishments joining the DexCom team as vice president of sales," said CEO Andy Rasdal. "Rod brings extensive experience in the field of diabetes and his most recent experience in successfully building the team and much of the infrastructure to launch the Deltec insulin pump is particularly relevant."
On Tuesday, DexCom fell 59 cents to $14.29.